Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Genome sequence and characteristics of Lrm1, a prophage from industrial Lactobacillus rhamnosus strain M1.

Durmaz E, Miller MJ, Azcarate-Peril MA, Toon SP, Klaenhammer TR.

Appl Environ Microbiol. 2008 Aug;74(15):4601-9. doi: 10.1128/AEM.00010-08. Epub 2008 Jun 6.

2.

A bioethanol process development unit: initial operating experiences and results with a corn fiber feedstock.

Schell DJ, Riley CJ, Dowe N, Farmer J, Ibsen KN, Ruth MF, Toon ST, Lumpkin RE.

Bioresour Technol. 2004 Jan;91(2):179-88.

PMID:
14592748
3.

Early microdose drug studies in human volunteers can minimise animal testing: Proceedings of a workshop organised by Volunteers in Research and Testing.

Combes RD, Berridge T, Connelly J, Eve MD, Garner RC, Toon S, Wilcox P.

Eur J Pharm Sci. 2003 May;19(1):1-11.

PMID:
12729856
4.

Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption.

Pace S, Longo A, Toon S, Rolan P, Evans AM.

Br J Clin Pharmacol. 2000 Nov;50(5):441-8.

5.

The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans.

Niopas I, Toon S, Aarons L, Rowland M.

Eur J Clin Pharmacol. 1999 Jul;55(5):399-404.

PMID:
10456491
6.

Enhanced cofermentation of glucose and xylose by recombinant Saccharomyces yeast strains in batch and continuous operating modes.

Toon ST, Philippidis GP, Ho NW, Chen Z, Brainard A, Lumpkin RE, Riley CJ.

Appl Biochem Biotechnol. 1997 Spring;63-65:243-55.

PMID:
18576085
7.

Atovaquone has no effect on the pharmacokinetics of phenytoin in healthy male volunteers.

Davis JD, Dixon R, Khan AZ, Toon S, Rolan PE, Posner J.

Br J Clin Pharmacol. 1996 Aug;42(2):246-8.

8.

The effect of food on cabergoline pharmacokinetics and tolerability in healthy volunteers.

Persiani S, Rocchetti M, Pacciarini MA, Holt B, Toon S, Strolin-Benedetti M.

Biopharm Drug Dispos. 1996 Jul;17(5):443-55.

PMID:
8830979
9.

The relevance of pharmacokinetics in the development of biotechnology products.

Toon S.

Eur J Drug Metab Pharmacokinet. 1996 Apr-Jun;21(2):93-103. Review.

PMID:
8839682
10.

Comprehensive pharmacokinetics of urinary human follicle stimulating hormone in healthy female volunteers.

le Cotonnec JY, Porchet HC, Beltrami V, Khan A, Toon S, Rowland M.

Pharm Res. 1995 Jun;12(6):844-50.

PMID:
7667188
11.

Absence of effect of ranitidine on blood alcohol concentrations when taken morning, midday, or evening with or without food.

Toon S, Khan AZ, Holt BI, Mullins FG, Langley SJ, Rowland MM.

Clin Pharmacol Ther. 1994 Apr;55(4):385-91.

PMID:
8162664
12.

Clinical pharmacology of recombinant human follicle-stimulating hormone. II. Single doses and steady state pharmacokinetics.

le Contonnec JY, Porchet HC, Beltrami V, Khan A, Toon S, Rowland M.

Fertil Steril. 1994 Apr;61(4):679-86.

PMID:
8150110
13.

Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH.

le Cotonnec JY, Porchet HC, Beltrami V, Khan A, Toon S, Rowland M.

Fertil Steril. 1994 Apr;61(4):669-78.

PMID:
8150109
14.

The effect of renal function on the pharmacokinetics of ranitidine.

Dixon JS, Borg-Costanzi JM, Langley SJ, Lacey LF, Toon S.

Eur J Clin Pharmacol. 1994;46(2):167-71.

PMID:
8039538
15.

Relevance of pharmacokinetic studies in volunteers.

Toon S.

Clin Pharmacokinet. 1993 Oct;25(4):259-62. No abstract available.

PMID:
8261710
16.

Human transbuccal absorption of diclofenac sodium from a prototype hydrogel delivery device.

Cassidy J, Berner B, Chan K, John V, Toon S, Holt B, Rowland M.

Pharm Res. 1993 Jan;10(1):126-9.

PMID:
8430049
17.

Effects of H2-receptor antagonists on blood alcohol levels.

Rowland M, Toon S.

JAMA. 1992 May 13;267(18):2470; author reply 2470-1. No abstract available.

PMID:
1349359
18.
19.

Further insight into the stereoselective interaction between warfarin and cimetidine in man.

Niopas I, Toon S, Rowland M.

Br J Clin Pharmacol. 1991 Oct;32(4):508-11.

20.

The pharmacokinetics of the enantiomers of flurbiprofen in patients with rheumatoid arthritis.

Young MA, Aarons L, Toon S.

Br J Clin Pharmacol. 1991 Jan;31(1):102-4.

21.

Investigations into the potential effects of multiple dose ketorolac on the pharmacokinetics and pharmacodynamics of racemic warfarin.

Toon S, Holt BL, Mullins FG, Bullingham R, Aarons L, Rowland M.

Br J Clin Pharmacol. 1990 Nov;30(5):743-50.

22.
23.

Pharmacokinetic and pharmacodynamic interaction between the antidepressant tianeptine and oxazepam at steady-state.

Toon S, Holt BL, Langley SJ, Mullins FG, Rowland M, Halliday MS, Salvadori C, Delalleau B.

Psychopharmacology (Berl). 1990;101(2):226-32.

PMID:
2349364
24.

Rate and extent of absorption of clonidine from a transdermal therapeutic system.

Toon S, Hopkins KJ, Aarons L, Rowland M.

J Pharm Pharmacol. 1989 Jan;41(1):17-21.

PMID:
2565958
25.

New York City dentist wins AIDS discrimination dispute.

Toon S.

Dentist. 1988 Nov-Dec;66(6):17-8. No abstract available.

PMID:
2978509
26.

A study to assess the anticholinergic activity of rolipram in healthy elderly volunteers.

Ross CE, Toon S, Rowland M, Murray GH, Meya U.

Pharmacopsychiatry. 1988 Sep;21(5):222-5.

PMID:
3227053
27.

Doctors using lasers risk problems without proper training, protection.

Toon S.

Occup Health Saf. 1988 Jul;57(7):30. No abstract available.

PMID:
3405576
28.

The racemic metoprolol H2-antagonist interaction.

Toon S, Davidson EM, Garstang FM, Batra H, Bowes RJ, Rowland M.

Clin Pharmacol Ther. 1988 Mar;43(3):283-9.

PMID:
3345620
29.

The effect of sulfinpyrazone on the disposition of pseudoracemic phenprocoumon in humans.

Heimark LD, Toon S, Gibaldi M, Trager WF, O'Reilly RA, Goulart DA.

Clin Pharmacol Ther. 1987 Sep;42(3):312-9.

PMID:
3621786
30.

Validation of assay methodology used in pharmacokinetic studies.

Aarons L, Toon S, Rowland M.

J Pharmacol Methods. 1987 Jul;17(4):337-46.

PMID:
3613604
31.

Enoxacin-warfarin interaction: pharmacokinetic and stereochemical aspects.

Toon S, Hopkins KJ, Garstang FM, Aarons L, Sedman A, Rowland M.

Clin Pharmacol Ther. 1987 Jul;42(1):33-41.

PMID:
3474093
32.

Pharmacokinetics of imipenem and cilastatin after their simultaneous administration to the elderly.

Toon S, Hopkins KJ, Garstang FM, Aarons L, Rowland M.

Br J Clin Pharmacol. 1987 Feb;23(2):143-9.

33.

Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man.

Toon S, Hopkins KJ, Garstang FM, Rowland M.

Eur J Clin Pharmacol. 1987;32(2):165-72.

PMID:
3582481
34.

The warfarin-cimetidine interaction: stereochemical considerations.

Toon S, Hopkins KJ, Garstang FM, Diquet B, Gill TS, Rowland M.

Br J Clin Pharmacol. 1986 Feb;21(2):245-6. No abstract available.

35.

The warfarin-sulfinpyrazone interaction: stereochemical considerations.

Toon S, Low LK, Gibaldi M, Trager WF, O'Reilly RA, Motley CH, Goulart DA.

Clin Pharmacol Ther. 1986 Jan;39(1):15-24.

PMID:
3943265
36.

Metabolic fate of phenprocoumon in humans.

Toon S, Heimark LD, Trager WF, O'Reilly RA.

J Pharm Sci. 1985 Oct;74(10):1037-40.

PMID:
4078699
37.

Pharmacokinetic implications of stereoselective changes in plasma-protein binding: warfarin/sulfinpyrazone.

Toon S, Trager WF.

J Pharm Sci. 1984 Nov;73(11):1671-3. No abstract available.

PMID:
6520783
38.
39.

Structure-pharmacokinetic relationships among the barbiturates in the rat.

Toon S, Rowland M.

J Pharmacol Exp Ther. 1983 Jun;225(3):752-63.

PMID:
6864531
40.

A simple restraining device for chronic pharmacokinetic and metabolism studies in rats.

Toon S, Rowland M.

J Pharmacol Methods. 1981 Jun;5(4):321-3.

PMID:
7311570
41.

Quantitative structure pharmacokinetic activity relationships with some tetracyclines [proceedings].

Toon S, Rowland M.

J Pharm Pharmacol. 1979 Dec;31 Suppl:43P. No abstract available.

PMID:
42718

Supplemental Content

Support Center